Judit Oláh
Judit Oláh
Improved understanding of melanoma genetics and immune regulatory pathways have culminated in the development of targeted and immunotherapies of the patients with metastatic melanoma. Recent advances in these oncological modalities have dra...
Review
Magyar onkologia. 2017 Jun 6;61(2):132-136. DOI: 2017
Lajos Géczi,Krisztián Nagyiványi,Anikó Maráz
Lajos Géczi
The authors briefly highlight the results of targeted therapy and present new solutions in kidney cancer immunotherapy. The important checkpoint inhibitors (anti-CTLA-4, -PD-1 and -PD-L1/2) and their combinations, together with the combinat...
Review
Magyar onkologia. 2017 Jun 6;61(2):126-131. DOI: 2017
[Recent advances of immunooncology in the treatment of solid tumours and haematological malignancies: the immune checkpoint inhibitors] [0.03%]
免疫检查点抑制剂在实体瘤和血液系统肿瘤治疗中的免疫肿瘤学新进展
Viktória Fésüs
Viktória Fésüs
Cancer immunotherapy is coming of age, as outstanding results can be achieved in the therapy of cancer with poor prognosis by altering the patients' immune system and by promoting the immune response against tumours. Amongst immunotherapies...
Review
Magyar onkologia. 2017 Jun 6;61(2):116-125. DOI: 2017
[Role of pembrolizumab in the treatment of non-small cell lung cancer (NSCLC)] [0.03%]
派姆单抗在非小细胞肺癌治疗中的作用
Gabriella Gálffy,Rita Puskás
Gabriella Gálffy
Lung cancer is the leading cause of cancer-related death, not only in our country but also worldwide. It is particularly the incidence and mortality regarding females that have increased significantly in recent years. For many years chemoth...
Review
Magyar onkologia. 2017 Mar 8;61(1):107-110. DOI: 2017
József Lövey
József Lövey
Radiation therapy traditionally plays a major role in the treatment of lymphoproliferative diseases. Diagnostics and treatment of these tumors improved tremendously in the recent decades. Molecular diagnostics is able to discriminate its su...
Review
Magyar onkologia. 2017 Mar 8;61(1):97-104. DOI: 2017
[Drug therapy of lymphomas] [0.03%]
[淋巴瘤的化疗]
Lajos Gergely
Lajos Gergely
The therapy of lymphomas has undergone a major expansion during the last decade. Novel therapeutic targets have appeared beyond classical chemotherapeutic combinations. These novel drugs have very pronounced action across lymphoma types, an...
Review
Magyar onkologia. 2017 Mar 8;61(1):89-96. DOI: 2017
[Primary central nervous system lymphoma: pathogenesis and histomorphology] [0.03%]
原发中枢神经系统淋巴瘤的发病机制及组织形态学研究进展
Gábor Méhes
Gábor Méhes
Lymphoproliferative diseases of the central nervous system are rare, diagnostics and treatment are accordingly challenging. Since the introduction of the 2008 WHO lymphoma classification, primary CNS DLBCL - also covering the associated pri...
Review
Magyar onkologia. 2017 Mar 8;61(1):81-87. DOI: 2017
[Invasive fungal infections in patients with haematological malignancies] [0.03%]
侵袭性真菌感染在血液系统恶性肿瘤患者中的应用
János Sinkó
János Sinkó
Invasive fungal diseases represent an ever changing field within infectology, profoundly affecting daily clinical activities of specialists in haematology. The dynamic development seen in oncohaematology creates novel risk groups of patient...
Review
Magyar onkologia. 2017 Mar 8;61(1):75-80. DOI: 2017
[Novelties and experience with tyrosine kinase inhibitor therapy in chronic myeloid leukemia] [0.03%]
慢性粒细胞白血病酪氨酸激酶抑制剂治疗新进展及经验体会
Júlia Gaál-Weisinger,Orsolya Mucsi,Gábor Körösmezey et al.
Júlia Gaál-Weisinger et al.
The introduction of tyrosine kinase inhibitor (TKI) treatment has resulted in dramatically improved survival in chronic myeloid leukemia (CML). With the new generation of TKIs the majority of patients reach optimal molecular response. Due t...
Review
Magyar onkologia. 2017 Mar 8;61(1):67-74. DOI: 2017
Richárd Kiss,Attila Péter Király,Júlia Gaál-Weisinger et al.
Richárd Kiss et al.
The last fifteen years brought a revolution both in treatment and diagnostics of chronic myeloid leukemia. Nowadays, the main method for monitoring of the disease is molecular monitoring with real-time PCR technology which can indicate trea...
Review
Magyar onkologia. 2017 Mar 8;61(1):57-66. DOI: 2017